PlainRecalls
FDA Drug Low Class III Ongoing

Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724. NDC: 0054-8550-25

Reported: November 1, 2023 Initiated: September 22, 2023 #D-0066-2024

Product Description

Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724. NDC: 0054-8550-25

Reason for Recall

Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.

Details

Recalling Firm
West-Ward Columbus Inc
Units Affected
2,673 cartons
Distribution
MS, OH
Location
Columbus, OH

Frequently Asked Questions

What product was recalled?
Methotrexate Tablets, USP, 2.5 mg, 10x10 Unit-Dose Tablets per carton, Rx only, Distributed by: West-Ward Pharmaceuticals Corp., Eatontown, NJ 07724. NDC: 0054-8550-25. Recalled by West-Ward Columbus Inc. Units affected: 2,673 cartons.
Why was this product recalled?
Failed Tablet/Capsule Specifications: Tablets were observed to have an unsmooth surface with two tablets demonstrating illegible tablet identification and scoring.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 1, 2023. Severity: Low. Recall number: D-0066-2024.